-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Elevance Health, Raises Price Target to $435

Benzinga·05/20/2026 13:09:09
Listen to the news
Mizuho analyst Ann Hynes maintains Elevance Health (NYSE:ELV) with a Outperform and raises the price target from $385 to $435.